Figure 7 — Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients

Research Paper|Volume 15, Issue 22|pp. 13265–13286

Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients

Back to articleFigure 7(7 of 7)

100%

Figure 7.KLRB1 overexpression was correlated with the OS in cancer patients on immunotherapy. (A) Anti-PD-1; (B) Pembrolizumab; (C) Anti-PD-L1; (D) Atezolizumab; (E) Ipilimumab; (F) Pretreatment; (G) Ontreatment. Abbreviation: OS: overall survival.